尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Doyle Thomas James. Insider active across 1 company, notably Kura Oncology, Inc.. Cumulatively, 11 disclosures have been published. Split: 0 buy · 4 sells. Total volume traded: €51k. Activity tracked since 7 February 2022. The latest transaction was filed on 27 January 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
DOYLE THOMAS JAMES is a declarant linked to Kura Oncology, Inc., where he is SVP, Finance & Accounting. He has 11 filings in total, and among the sampled recent filings between 2022-02-09 and 2026-01-27, sales amount to EUR 51193 and the modal transaction nature is Attribution.